Dr Robert Whiley, BSc, PhD
Email: email@example.comTelephone: +44 20 7882 2389Room Number: Blizard Building
Rob Whiley was awarded a BSc (Hons) in Microbiology from the University of Leeds and a PhD from London University in 1987 on the classification and diversity of the oral streptococci. In 1988 he obtained a post as Research Assistant in the Department of Oral Microbiology in the London Hospital Medical College followed by a lectureship in 1991. In 2001 he was appointed to Senior Lecturer in Oral Microbiology within the Department of Clinical and Diagnostic Oral Sciences, Barts and The London, Queen Mary's School of Medicine and Dentistry. He has over 50 papers in the field of oral microbiology in peer reviewed journals. The majority of these focus on the oral or viridans streptococci of which he has described eight new species plus additional centres of genetic variation, virulence factors and disease associations. He was recently invited to contribute the Streptococcus and Streptococcaceae chapters for the forthcoming 2nd edition of Bergey's Manual of Systematic Bacteriology.
Teaching administration includes Convenor of the BDS Human Health & Disease (Pathology and related subjects) module.
Oral microbiology with focus on diversity and pathogenicity. Specific current areas of research include the Anginosus group of streptococci (AGS) and their virulence determinants and the role of these streptococci in purulent infections at oral and non-oral sites including brain abscesses. Projects on the AGS include studies on intermedilysin, a human specific toxin expressed by Streptococcus intermedius and the role of the commensal AGS in pathogenic processes. Currently I am looking at the partnerships between the AGS and overt pathogens such as Pseudomonas aeruginosa which co-infect the lungs of cystic fibrosis patients.
Antimicrobial research, funded by the EPSRC, is focussed on developing a self-disinfecting dental alginate impression material using a low pH formulation and nitric oxide release. The material is being formulated to have antibacterial, antiviral and antifungal activities.